Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Sickle Cell Disease Treatment Market from 2024 to 2033?

The sickle cell disease treatment market size is expected to rise from $2.46 billion in 2023 to $2.95 billion in 2024 at a compound annual growth rate (CAGR) of 20.0%. This growth is driven by a better understanding of the disease, blood transfusions, pain management, and hydroxyurea therapy.

The sickle cell disease treatment market is forecast to grow rapidly, reaching $5.75 billion in 2028, at a CAGR of 18.1%. Growth factors include gene editing, gene therapy, new drug development, and telemedicine. Trends include curative therapies, pain management alternatives, global collaborations, and patient advocacy.

Claim Your Free Sample of the Global Sickle Cell Disease Treatment Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13048&type=smp

The rising demand for blood transfusions is expected to drive the sickle cell disease treatment market. Blood transfusions, which aid oxygen delivery in sickle cell patients, are essential for managing symptoms. In 2021, UK blood donations reached 1.7 million, and in the US, daily needs include 29,000 units of red blood cells. Consequently, the demand for blood transfusions is fueling growth in the sickle cell disease treatment market.

1) By Treatment Modality: Blood Transfusion, Pharmacotherapy, Bone Marrow Transplant

2) By Disease Type: Sickle Cell Anemia, Hemoglobin Sickle C Disease (HbSC), Other Disease Types

3) By Route Of Administration: Oral, Parenteral

4) By End-User: Hospitals, Specialty Clinics, Other End-Users

In the sickle cell disease treatment market, companies are focusing on new product approvals to strengthen their market position. Drug approval is crucial to offering effective treatment for this lifelong condition. For example, in December 2021, Global Therapeutics Inc. announced that the FDA granted rapid approval for Oxbryta (voxelotor) tablets, which treat sickle cell disease (SCD) in children aged 4 to 11. Oxbryta is the only FDA-approved medication specifically designed to prevent sickle hemoglobin polymerization, which causes red blood cell destruction in SCD. It works by increasing fetal hemoglobin production and is administered once daily as a subcutaneous injection.

Order Now for Fast Delivery of Your Sickle Cell Disease Treatment Market Report!

https://www.thebusinessresearchcompany.com/report/sickle-cell-disease-treatment-global-market-report

North America was the largest region in the healthcare transportation service market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare transportation service market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Sickle Cell Disease Treatment Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the sickle cell disease treatment market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Sickle Cell Disease Treatment Market Include

1. Sickle Cell Disease Treatment Market Executive Summary

2. Sickle Cell Disease Treatment Market Segments

3. Sickle Cell Disease Treatment Market Size And Template Market Growth Rate

4. Key Sickle Cell Disease Treatment Market Trends

5. Major Sickle Cell Disease Treatment Market Drivers

……

25. Key Mergers And Acquisitions In The Sickle Cell Disease Treatment Market

26. Top Sickle Cell Disease Treatment Companies

27. Sickle Cell Disease Treatment Market Opportunities And Strategies

28. Sickle Cell Disease Treatment Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Analysis of Blood Transfusion Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Patient Blood Management Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

Anemia and Other Blood Disorder Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: